These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 26559642)
1. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells. Ananta JS; Paulmurugan R; Massoud TF Mol Pharm; 2015 Dec; 12(12):4509-17. PubMed ID: 26559642 [TBL] [Abstract][Full Text] [Related]
2. Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a "Personalized" Anti-microRNA Therapy. Ananta JS; Paulmurugan R; Massoud TF Mol Pharm; 2016 Sep; 13(9):3164-75. PubMed ID: 27508339 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells. Wong ST; Zhang XQ; Zhuang JT; Chan HL; Li CH; Leung GK Anticancer Res; 2012 Jul; 32(7):2835-41. PubMed ID: 22753745 [TBL] [Abstract][Full Text] [Related]
4. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539 [TBL] [Abstract][Full Text] [Related]
5. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma. She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996 [TBL] [Abstract][Full Text] [Related]
6. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
7. Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy. Qian X; Ren Y; Shi Z; Long L; Pu P; Sheng J; Yuan X; Kang C Mol Pharm; 2012 Sep; 9(9):2636-45. PubMed ID: 22853427 [TBL] [Abstract][Full Text] [Related]
8. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma. Lan F; Pan Q; Yu H; Yue X J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372 [TBL] [Abstract][Full Text] [Related]
9. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
10. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met. Lan F; Yu H; Hu M; Xia T; Yue X J Neurochem; 2015 Oct; 135(2):274-86. PubMed ID: 26250785 [TBL] [Abstract][Full Text] [Related]
11. MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor. Chen Y; Li R; Pan M; Shi Z; Yan W; Liu N; You Y; Zhang J; Wang X J Neurooncol; 2017 Jul; 133(3):477-485. PubMed ID: 28501897 [TBL] [Abstract][Full Text] [Related]
12. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811 [TBL] [Abstract][Full Text] [Related]
13. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225 [TBL] [Abstract][Full Text] [Related]
14. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide. Zhang S; Wan Y; Pan T; Gu X; Qian C; Sun G; Sun L; Xiang Y; Wang Z; Shi L J Mol Neurosci; 2012 Jun; 47(2):346-56. PubMed ID: 22528454 [TBL] [Abstract][Full Text] [Related]
16. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells. Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines. Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310 [TBL] [Abstract][Full Text] [Related]
18. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells. Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. Shi L; Zhang S; Feng K; Wu F; Wan Y; Wang Z; Zhang J; Wang Y; Yan W; Fu Z; You Y Int J Oncol; 2012 Jan; 40(1):119-29. PubMed ID: 21879257 [TBL] [Abstract][Full Text] [Related]
20. Growth-inhibitory and chemosensitizing effects of microRNA-31 in human glioblastoma multiforme cells. Zhou RJ; Xu XY; Liu BX; Dai WZ; Cai MQ; Bai CF; Zhang XF; Wang LM; Lin L; Jia SZ; Wang WH Int J Mol Med; 2015 Oct; 36(4):1159-64. PubMed ID: 26310668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]